GSK on Monday provided two updates on the legal cases surrounding its heartburn drug Zantac (ranitidine), including a voluntary plaintiff dismissal and an appeal of a recent decision by the Delaware State Court.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,